Abstract Details

Title Preclinical Characterization of SAGE-217 in a Rodent Model of Oral Dyskinesia

Topic Movement Disorders

Presentation(s) P5 - (-)

Poster/Presentation
Number 021

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Gabriel M. Belfort, MD PRESENTER	Dr. Belfort has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Belfort has received stock or an ownership interest from Praxis Precision Medicines. Dr. Belfort has received intellectual property interests from a discovery or technology relating to health care.
Alison Althaus	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Albert Robichaud, PhD (Sage Therapeutics)	No disclosure on file
James Doherty, PhD (Sage Therapeutics)	Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics.